Cart
0

Exosome Diagnostic and Therapeutic Market by Application (Diagnostic and Therapeutic), Product (Instrument, Reagent and Software) and End-User (Cancer Institute, Hospital, Diagnostic Center, and Others) - Global Opportunity Analysis and Industry Forecasts, 2014-2022

Get 20% Free Customization In This Report
LI_161723
Pages: 115
Sep 2016 | 3750 Views
 
Author's : Sachin Sinha
Tables: 48
Charts: 44
 

Exosome Diagnostic and Therapeutic Market Overview:

Exosome Diagnostic and Therapeutic Market was valued at $39 million, and is expected to reach $368 million by 2022, supported by a CAGR of 37.8%. Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses the immune function by inducing apoptosis of activated cytotoxic T cells, which enable tumor progression in the human body. In addition, exosomes also stimulate the angiogenesis and migration leading to metastasis. Moreover, exosomes trigger apoptosis in anti-tumor immune cells through tumor necrosis factor pathways. Furthermore, healthcare professionals use exosomes to diagnose cancer, which helps in profiling genetic changes in tumors and also prevent the spread of the disease.

Exosome Diagnostic and Therapeutic Market

Get more information on this report : Request Sample Pages

This report covers information on various types of exosome products such as instruments, reagents, and software that are manufactured for medical and research purposes in compliance with the European Medical Association (EMA), the U.S. Food and Drugs Administration (FDA), Conformit Europene (CE) and other regulatory authorities. Moreover, this market also focuses on the application and end users of the market. By application, the market is segmented into diagnostic and therapeutic applications. Based on end user, the market is categorized into cancer institute, hospital, diagnostic centers, and others.

Exosome Diagnostic and Therapeutic Market

Get more information on this report : Request Sample Pages

 

Exosome Diagnostic and Therapeutic Market

Get more information on this report : Request Sample Pages

Experts Perspective

In accordance to several interviews conducted, the utilization of exosome isolation instrument is expected to witness a significant rise with increasing focus on life science research, rise in diagnostic procedures for cancer, and innovative and advanced applications of isolation kits.

The exosome diagnostic and therapeutic industry is the point of interest in the liquid biopsy market as it is one of the emerging biomarker based procedures for the diagnosis of cancer. Moreover, remarkable technological advancements in the exosome isolation kits and reagents to provide advanced extraction procedures from the body fluids.

According to the experts from leading companies in operating in this market, increase in prevalence of cancer, technological advancements, and rising emphasis on early diagnosis of cancer are some of the major factors driving market growth. However, lack of awareness and stringent regulations for the approval of products used in exosome-based research hamper the growth of the market.

Increasing Prevalence of Cancer Across the World

Exosomes are nano vesicles that comprise proteins, DNA and RNA, with huge potential in the diagnosis of cancer. Increase in prevalence of cancer play an important role in the market growth.
For instance, according to Centers for Disease Control and Prevention (CDC), in 2012, 8.2 million cancer-related deaths were reported around the world and are expected to reach 19.3 million by 2025.
The leading key players operating in this market focus to expand their business operations in the emerging countries. The companies operating in the market have consistently introduced innovative solutions to enhance their product portfolio. Product launch and partnerships are observed as the two prominent growth strategies adopted by the key market players. The major players profiled in this report include Aethlon Medical, Inc. (U.S.), Exosome Diagnostics Inc. (U.S.), NanoSomix Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Malvern Instruments Ltd. (U.K,), System Biosciences Inc. (U.S.), NX Pharmagen (U.S.), Sistemic Inc. (U.K.), Capricor Therapeutics (U.S.), and Exiqon A/S (Denmark).

Other players in the value chain include 101BIO, AMS Biotechnology Limited, Therapeutic Solutions International, Inc., ReNeuron Group plc, Immune Therapy Holdings AB, ExoCyte Therapeutics Pte Ltd, Cell Guidance Systems LLC, BioRegenerative Sciences, Inc., Evomic Science LLC, and Norgen Biotek Corp.

Key Benefits

  • The study provides an in-depth analysis of the exosome diagnostic and therapeutic market, with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive market analysis by product assist in the treatment of various chronic and infectious diseases such as cancer, cardiovascular diseases, and other diseases.
  • Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.
  • Key market players are profiled and their strategies are analyzed thoroughly, which predicts the competitive outlook of the market.

Exosome Diagnostic and Therapeutic Market Key Segments:

By Application

  • Diagnostic
  • Therapeutic

By Product

  • Instrument
  • Reagent
  • Software

By End User

  • Cancer Institute
  • Hospital
  • Diagnostic Center
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Rest of Asia-Pacific
  • LAMEA
 

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope

3.1.1 Top investment pockets
3.1.2 Top winning strategies

3.2 Porters Five Forces analysis

3.2.1 Bargaining power of the suppliers
3.2.2 Bargaining power of buyers
3.2.3 Threat of new entrants
3.2.4 Intensity of rivalry
3.2.5 Threat of substitutes

3.3 Market dynamics

3.3.1 Drivers

3.3.1.1 increasing prevalence of cancer
3.3.1.2 initiatives implemented by the government and non-government associations for rise in health awareness
3.3.1.3 technological advancements in exosomes isolation and analytical procedures
3.3.1.4 Innovative and advanced Applications of exosomes

3.3.2 Restraints

3.3.2.1 Technical difficulties in the usage of exosomes
3.3.2.2 Stringent regulatory requirements for the approval and commercialization of Exosome diagnostic and therapeutic products
3.3.2.3 low awareness and lack of skilled professionals required for the isolation of exosomes

3.3.3 Opportunities

3.3.3.1 developing economies offer lucarative growth opportunities

Chapter: 4 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY APPLICATION

4.1 Overview
4.2 Diagnostic application

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Therapeutic application

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

Chapter: 5 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY PRODUCT

5.1 Overview
5.2 Instrument

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast

5.3 Reagents

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

5.4 Software

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast

Chapter: 6 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY END USER

6.1 Overview

6.1.1 Market size and forecast

6.2 Cancer Institutes

6.2.1 Market size and forecast

6.3 Hospitals

6.3.1 Market size and forecast

6.4 Diagnostic Centers

6.4.1 Market size and forecast

6.5 Others

6.5.1 Market size and forecast

Chapter: 7 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY GEOGRAPHY, 2015-2022

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.2.4 U.S.: market size and forecast
7.2.5 Canada market size and forecast
7.2.6 Mexico: market size and forecast

7.3 Europe

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.3.4 Germany: market size and forecast
7.3.5 France: market size and forecast
7.3.6 U.K.: market size and forecast
7.3.7 Italy market size and forecast
7.3.8 Rest of Europe: market size and forecast

7.4 Asia-Pacific

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.4.4 Japan: market size and forecast
7.4.5 China market size and forecast
7.4.6 Rest of Asia-Pacific: market size and forecast

7.5 LAMEA

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast

Chapter: 8 COMPANY PROFILES

8.1 Aethlon Medical, Inc.

8.1.1 Company overview
8.1.2 Operating business segments
8.1.3 Business performance
8.1.4 Key strategic moves & developments

8.2 Exosome Diagnostics, Inc.

8.2.1 Company overview
8.2.2 Operating business segments
8.2.3 Business performance
8.2.4 Key strategic moves & developments

8.3 NanoSomix, Inc.

8.3.1 Company overview
8.3.2 Operating business segments
8.3.3 Business performance
8.3.4 Key strategic moves & developments

8.4 Thermo Fisher Scientific, Inc.

8.4.1 Company overview
8.4.2 Operating business segments
8.4.3 Business performance
8.4.4 Key strategic moves & developments

8.5 Malvern Instruments Ltd

8.5.1 Company overview
8.5.2 Operating business segments
8.5.3 Business performance
8.5.4 Key strategic moves & developments

8.6 System Biosciences, Inc.

8.6.1 Company overview
8.6.2 Operating business segments
8.6.3 Business performance
8.6.4 Key strategic moves & developments

8.7 NX PHARMAGEN

8.7.1 Company overview
8.7.2 Operating business segments
8.7.3 Business performance
8.7.4 Key strategic moves & developments

8.8 Sistemic Ltd.

8.8.1 Company overview
8.8.2 Operating business segments
8.8.3 Business performance
8.8.4 Key strategic moves & developments

8.9 Capricor Therapeutics, Inc.

8.9.1 Company overview
8.9.2 Operating business segments
8.9.3 Business performance
8.9.4 Key strategic moves & developments

8.10 Exiqon A/S

8.10.1 Company overview
8.10.2 Operating business segments
8.10.3 Business performance
8.10.4 Key strategic moves & developments

*Other players in the value chain include (players not profiled in the report)

  • 101BIO
  • AMS Biotechnology Limited
  • Therapeutic Solutions International, Inc.
  • ReNeuron Group plc
  • Immune Therapy Holdings AB
  • ExoCyte Therapeutics Pte Ltd
  • Cell Guidance Systems LLC
  • BioRegenerative Sciences, Inc.
  • Evomic Science LLC
  • Norgen Biotek Corp.

*Profiles of these players are not included. The same will be included on request

List of Figures

FIG. 1 TOP INVESTMENT POCKETS IN WORLD EXOSOME DAIGNOSTIC AND THERAPEUTIC MARKET
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 20142016
FIG. 3 PORTERS FIVE FORCES ANALYSIS
FIG. 4 TOP IMPACTING FACTORS: WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET
FIG. 5 NUMBER OF CANCER PATIENTS IN MAJOR COUNTRIES IN 2012 (AGE- STANDARDISED RATE PER 100,000)
FIG. 6 APPLICATIONS OF EXOSOMES
FIG. 7 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY APPLICATION, 2015 & 2022 (% SHARE)
FIG. 8 WORLD EXOSOME DIAGNOSTIC MARKET, 20142022 ($THOUSAND)
FIG. 9 WORLD EXOSOME DIAGNOSTIC MARKET, BY GEOGRAPHY, 2015 & 2022 (% SHARE)
FIG. 10 WORLD EXOSOME THERAPEUTIC MARKET, 20142022 ($THOUSAND)
FIG. 11 WORLD EXOSOME THERAPEUTIC MARKET, BY GEOGRAPHY, 2015 & 2022 (% SHARE)
FIG. 12 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY PRODUCT, 2015 & 2022 (% SHARE)
FIG. 13 WORLD INSTRUMENTS MARKET FOR EXOSOME DIAGNOSTIC & THERAPEUTIC, 20142022 ($THOUSAND)
FIG. 14 WORLD INSTRUMENTS MARKET FOR EXOSOME DIAGNOSTIC & THERAPEUTIC, BY GEOGRAPHY, 2015 & 2022 (% SHARE)
FIG. 15 WORLD REAGENTS MARKET FOR EXOSOME DIAGNOSTIC & THERAPEUTIC, 20142022 ($THOUSAND)
FIG. 16 WORLD REAGENTS MARKET FOR EXOSOME DIAGNOSTIC & THERAPEUTIC, BY GEOGRAPHY, 2015 & 2022 (% SHARE)
FIG. 17 WORLD SOFTWARE MARKET FOR EXOSOME DIAGNOSTIC & THERAPEUTIC, 20142022 ($THOUSAND)
FIG. 18 WORLD SOFTWARE MARKET FOR EXOSOME DIAGNOSTIC & THERAPEUTIC, BY GEOGRAPHY, 2015 & 2022 (% SHARE)
FIG. 19 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY END USER, 2015 & 2022 (% SHARE)
FIG. 20 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FOR CANCER INSTITUTE, 20142022 ($THOUSAND)
FIG. 21 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FOR CANCER INSTITUTE, BY GEOGRAPHY, 2015 & 2022 (% SHARE)
FIG. 22 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FOR HOSPITAL, 20142022 ($THOUSAND)
FIG. 23 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FOR HOSPITAL, BY GEOGRAPHY, 2015 & 2022 (% SHARE)
FIG. 24 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FOR DIAGNOSTIC CENTER, 20142022 ($THOUSAND)
FIG. 25 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FOR DIAGNOSTIC CENTER, BY GEOGRAPHY, 2015 & 2022 (% SHARE)
FIG. 26 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FOR OTHER END USER, 20142022 ($THOUSAND)
FIG. 27 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FOR OTHER END USER, BY GEOGRAPHY, 2015 & 2022 (% SHARE)
FIG. 28 U.S.: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, 20142022 ($THOUSAND)
FIG. 29 CANADA: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, 20142022 ($THOUSAND)
FIG. 30 MEXICO: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, 20142022 ($THOUSAND)
FIG. 31 GERMANY: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, 20142022 ($THOUSAND)
FIG. 32 FRANCE: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, 20142022 ($THOUSAND)
FIG. 33 U.K.: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, 20142022 ($THOUSAND)
FIG. 34 ITALY: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, 20142022 ($THOUSAND)
FIG. 35 REST OF EUROPE: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, 20142022 ($THOUSAND)
FIG. 36 JAPAN: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, 20142022 ($THOUSAND)
FIG. 37 CHINA: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, 20142022 ($THOUSAND)
FIG. 38 REST OF ASIA-PACIFIC: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, 20142022 ($THOUSAND)
FIG. 39 AETHLON MEDICAL: REVENUE GENERATED, 20132015 ($MILLION)
FIG. 40 THERMO FISHER: REVENUE, 20132015 ($MILLION)
FIG. 41 THERMO FISHER - REVENUE, BY SEGMENT, 2015 (%)
FIG. 42 THERMO FISHER REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 43 CAPRICOR THERAPEUTICS, REVENUE 20132015 ($MILLION)
FIG. 44 EXIQON, REVENUE 20132015 ($MILLION)

List of Tables

TABLE 1 EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY APPLICATION, 20142022 ($THOUSAND)
TABLE 2 WORLD EXOSOME DIAGNOSTIC MARKET, BY GEOGRAPHY, 20142022 ($THOUSAND)
TABLE 3 EXOSOME THERAPEUTIC MARKET, BY GEOGRAPHY, 20142022 ($THOUSAND)
TABLE 4 EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY PRODUCT, 20142022 ($THOUSAND)
TABLE 5 WORLD INSTRUMENTS MARKET FOR EXOSOME DIAGNOSTIC & THERAPEUTIC, BY GEOGRAPHY, 20142022 ($THOUSAND)
TABLE 6 WORLD REAGENTS MARKET FOR EXOSOME DIAGNOSTIC & THERAPEUTIC, BY GEOGRAPHY, 20142022 ($THOUSAND)
TABLE 7 SOFTWARE MARKET FOR EXOSOME DIAGNOSTIC & THERAPEUTIC, BY GEOGRAPHY, 20142022 ($THOUSAND)
TABLE 8 EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY END USER, 20142022, ($THOUSAND)
TABLE 9 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FOR CANCER INSTITUTE, BY GEOGRAPHY, 20142022 ($THOUSAND)
TABLE 10 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FOR HOSPITALS, BY GEOGRAPHY, 20142022 ($THOUSAND)
TABLE 11 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FOR DIAGNOSTIC CENTER, BY GEOGRAPHY, 20142022 ($THOUSAND)
TABLE 12 WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FOR OTHER END USER, BY GEOGRAPHY, 20142022 ($THOUSAND)
TABLE 13 WORLD: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY GEOGRAPHY, 20142022 ($THOUSAND)
TABLE 14 NORTH AMERICA: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY COUNTRY, 20142022 ($THOUSAND)
TABLE 15 NORTH AMERICA: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY APPLICATION, 20142022 ($THOUSAND)
TABLE 16 NORTH AMERICA: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY PRODUCT, 20142022 ($THOUSAND)
TABLE 17 NORTH AMERICA: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY END USER, 20142022 ($THOUSAND)
TABLE 18 EUROPE: EXOSOME DIAGNOSTIC AND THERAPEUTIC S MARKET, BY COUNTRY, 20142022 ($THOUSAND)
TABLE 19 EUROPE: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY APPLICATION, 20142022 ($THOUSAND)
TABLE 20 EUROPE: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY PRODUCT, 20142022 ($THOUSAND)
TABLE 21 EUROPE: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY END USER, 20142022 ($THOUSAND)
TABLE 22 ASIA-PACIFIC: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY COUNTRY, 20142022 ($THOUSAND)
TABLE 23 ASIA-PACIFIC: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY APPLICATION, 20142022 ($THOUSAND)
TABLE 24 ASIA-PACIFIC: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY PRODUCT, 20142022 ($THOUSAND)
TABLE 25 ASIA-PACIFIC: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY END USER, 20142022 ($THOUSAND)
TABLE 26 LAMEA: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY APPLICATION, 20142022 ($THOUSAND)
TABLE 27 LAMEA: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY PRODUCT, 20142022 ($THOUSAND)
TABLE 28 LAMEA: EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY END USER, 20142022 ($THOUSAND)
TABLE 29 AETHLON MEDICAL - COMPANY SNAPSHOT
TABLE 30 AETHLON MEDICAL - OPERATING SEGMENTS
TABLE 31 EXOSOME DIAGNOSTICS- COMPANY SNAPSHOT
TABLE 32 EXOSOME DIAGNOSTICS - OPERATING SEGMENTS
TABLE 33 NANOSOMIX- COMPANY SNAPSHOT
TABLE 34 NANOSOMIX - OPERATING SEGMENTS
TABLE 35 THERMO FISHER - COMPANY SNAPSHOT
TABLE 36 THERMO FISHER - OPERATING SEGMENTS
TABLE 37 MALVERN INSTRUMENTS - COMPANY SNAPSHOT
TABLE 38 MALVERN - OPERATING SEGMENTS
TABLE 39 SBI- COMPANY SNAPSHOT
TABLE 40 SYSTEM BIOSCIENCES -PRODUCT & SOLUTIONS
TABLE 41 NX PHARMAGEN- COMPANY SNAPSHOT
TABLE 42 NX PHARMAGEN PRODUCT CATEGORY
TABLE 43 SISTEMIC - COMPANY SNAPSHOT
TABLE 44 SISTEMIC SOLUTION & SERVICES
TABLE 45 CAPRICOR THERAPEUTICS- COMPANY SNAPSHOT
TABLE 46 CAPRICOR THERAPEUTICS - OPERATING SEGMENTS
TABLE 47 EXIQON- COMPANY SNAPSHOT
TABLE 48 EXIQON - OPERATING SEGMENTS

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Exosome Diagnostic and Therapeutic Market- Global Opportunity Analysis and Industry Forecasts, 2014-2022

  • Online Only
  • $4176
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo